Qingfeng Shi
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Pulmonary Hypertension Research and Treatments
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Wnt/β-catenin signaling in development and cancer 1
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Co-authors
- Bin Huang (2 shared papers)Feng Gao (2 shared papers)Wen Li (2 shared papers)Ling Peng (2 shared papers)Changming Wang (1 shared paper)Jie Meng (1 shared paper)Cheng-ping Hu (1 shared paper)Jiahui Wu (1 shared paper)
- Journals
- Cell Biochemistry and Biophysics (1 paper)Breast Cancer Targets and Therapy (1 paper)Infection Control and Hospital Epidemiology (1 paper)Cell Death and Disease (1 paper)International Journal of Nanomedicine (1 paper)
- Partner nations
- China
In The Last Decade
Qingfeng Shi
7 papers receiving 298 citations
Qingfeng Shi's Hit Papers
Peers
Comparison fields: 5 of 70
- Pulmonary and Respiratory Medicine 126
- Immunology 50
- Molecular Biology 135
- Nephrology 12
- Molecular Medicine 8
Countries citing papers authored by Qingfeng Shi
This map shows the geographic impact of Qingfeng Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingfeng Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingfeng Shi more than expected).
Fields of papers citing papers by Qingfeng Shi
This network shows the impact of papers produced by Qingfeng Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingfeng Shi. The network helps show where Qingfeng Shi may publish in the future.
Co-authors
The 24 scholars most cited alongside Qingfeng Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial–mesenchymal transition and inflammation Hit paper breakdown → | 2020 | 268 |
| 2 | 2021 | 12 | |
| 3 | 2017 | 6 | |
| 4 | 2025 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2021 | 4 | |
| 7 | 2023 | 1 | |
| 8 | 2025 | 0 |
About Qingfeng Shi
Qingfeng Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Endocrinology, Diabetes and Metabolism, having authored 8 papers that have together received 299 indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), Thyroid Cancer Diagnosis and Treatment (2 papers), Thyroid Disorders and Treatments (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), Nosocomial Infections in ICU (1 paper), Cancer, Lipids, and Metabolism (1 paper), Central Venous Catheters and Hemodialysis (1 paper) and Wnt/β-catenin signaling in development and cancer (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (126 citations), Immunology (50 citations), Molecular Biology (135 citations), Nephrology (12 citations) and Molecular Medicine (8 citations). Qingfeng Shi has collaborated with scholars based in China. Frequent co-authors include Bin Huang, Feng Gao, Wen Li, Ling Peng, Changming Wang, Jie Meng, Cheng-ping Hu, Jiahui Wu, Keqiang Qiu and Yonghong Liu. Their work appears in journals such as Cell Biochemistry and Biophysics, Breast Cancer Targets and Therapy, Infection Control and Hospital Epidemiology, Cell Death and Disease and International Journal of Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.